← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 2.0% below its 1-year high (as of 2026-09-17). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 8.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Owner-earnings 10-yr IRR 10–30 points over Treasuries, yield ≤ 25% · bought the day of the annual report, held 12 months
Could be luck Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +2.9 pts (823 entries, 255 companies, could be luck). 47% of entries beat the S&P; 18% beat it by 30 points or more; 27% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +1.2 pts.
+2.9 ptsvs S&P, average
47%beat the S&P
18%up 30+ pts vs S&P
27%down 20+ pts vs S&P
+6.0 ptsvs small caps, 12 mo
−14.6 pts 2024worst year to buy ?
1.8luck check ?
Does the holding period matter?3 mo: −0.5 pts 47% beat6 mo: +0.1 pts 45% beat12 mo: +2.9 pts 47% beat24 mo: +3.3 pts 42% beat3 yr, per yr: −0.9 pts 39% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today686+1.9 pts t 1.2+5.3 pts
Sell-off (S&P ≥10% off high)137+7.9 pts t 1.4+9.6 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing255+0.9 pts t 0.4−5.1 pts
Retail & consumer106+10.5 pts t 1.9+1.9 pts
Services79−3.2 pts t -0.5−1.9 pts
Energy69+3.1 pts t 0.5−4.9 pts
Other61−4.4 pts t -0.8−3.3 pts
Tech hardware & semis58−2.8 pts t -0.6−1.4 pts
Finance & real estate46+5.9 pts t 1.5+6.8 pts
Biotech & pharma28−5.0 pts t -0.7−4.3 pts

Holds up out of sample? Before 2018: +5.1 pts (n 291, t 2.3). From 2018: +1.7 pts (n 532, t 0.8). Same sign in both halves.

Year201120122013201420152016201720182019202020212022202320242025
vs S&P−11 pts+5 pts+6 pts−5 pts−4 pts+17 pts+8 pts−10 pts−14 pts+46 pts+8 pts+8 pts−14 pts−15 pts+3 pts
n12943515669425362725676876957

Read the research behind this screen: Ranking companies as equity bonds: the top fifth beats the bottom fifth by a wide margin → · Test your own combination in the Screen Lab →

Same definitions as the table: coupon = 3-yr average owner earnings, growth capped, 15× exit. Historical IRR uses a 5-yr revenue CAGR as the growth proxy where the DCF rate is not available point-in-time. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

NUW
Nuveen AMT-Free Municipal Value Fund
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NVA
Nova Minerals Ltd
Below Treasuries
Basic Materials Risk 51 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NVAWW
Nova Minerals Ltd
Below Treasuries
Basic Materials Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NVAX
NOVAVAX INC
Below Treasuries
Healthcare Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +37.0%/yr vs model +2.0% · above model
NVCR
NovoCure Ltd
Below Treasuries
Healthcare Risk 50 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +35.6%/yr vs model +5.2% · above model
NVCT
Nuvectis Pharma, Inc.
Below Treasuries
Healthcare Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NVG
Nuveen AMT-Free Municipal Credit Income Fund
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NVMI
NOVA LTD.
Below Treasuries
Healthcare Risk 43 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NVNI
Nvni Group Ltd
Below Treasuries
Technology Risk 61 · High
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NVNIW
Nvni Group Ltd
Below Treasuries
Technology Risk 54 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NVNO
enVVeno Medical Corp
Below Treasuries
Healthcare Risk 43 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NVO
NOVO NORDISK A S
Below Treasuries
Healthcare
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NVTS
Navitas Semiconductor Corp
Below Treasuries
Technology Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +9.7%/yr vs model +50.0% · below model
NVX
NOVONIX Ltd
Below Treasuries
Technology Risk 40 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NWAX
New America Acquisition I Corp.
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NWG
NatWest Group plc
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NWGL
CL Workshop Group Ltd
Below Treasuries
Industrials Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NXDT
NEXPOINT DIVERSIFIED REAL ESTATE TRUST
Below Treasuries
Financial Services Risk 36 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NXE
NexGen Energy Ltd.
Below Treasuries
Basic Materials Risk 52 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NXG
NXG NextGen Infrastructure Income Fund
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NXGL
NEXGEL, INC.
Below Treasuries
Healthcare Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -50.0%/yr vs model +50.0% · below model
NXL
Nexalin Technology, Inc.
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +111.9%/yr vs model +20.3% · above model
NXP
NUVEEN SELECT TAX FREE INCOME PORTFOLIO
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NXTC
NextCure, Inc.
Below Treasuries
Healthcare Risk 32 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NXTS
Nexentis Technologies Inc.
Below Treasuries
Healthcare Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +31.2%/yr vs model +15.0% · above model
NYAX
Nayax Ltd.
Below Treasuries
Technology Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NYXH
Nyxoah SA
Below Treasuries
Healthcare Risk 51 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
NZF
Nuveen Municipal Credit Income Fund
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OABI
OmniAb, Inc.
Below Treasuries
Industrials Risk 38 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +52.7%/yr vs model +2.0% · above model
OACC
Oaktree Acquisition Corp. III Life Sciences
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OACCU
Oaktree Acquisition Corp. III Life Sciences
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OACCW
Oaktree Acquisition Corp. III Life Sciences
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OBA
Oxley Bridge Acquisition Ltd
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OBAI
Our Bond, Inc.
Below Treasuries
Communication Services Risk 64 · High
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OBAWU
Oxley Bridge Acquisition Ltd
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OBAWW
Oxley Bridge Acquisition Ltd
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OBE
OBSIDIAN ENERGY LTD.
Below Treasuries
Energy Risk 32 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OBIO
Orchestra BioMed Holdings, Inc.
Below Treasuries
Healthcare Risk 40 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +44.1%/yr vs model +15.0% · above model
OBTC
Osprey Bitcoin Trust
Below Treasuries
Financial Services Risk 32 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OCCI
OFS Credit Company, Inc.
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OCCIM
OFS Credit Company, Inc.
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OCCIN
OFS Credit Company, Inc.
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OCGN
Ocugen, Inc.
Below Treasuries
Healthcare Risk 60 · High
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +70.9%/yr vs model +15.0% · above model
OCS
Oculis Holding AG
Below Treasuries
Healthcare
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OCSAW
Oculis Holding AG
Below Treasuries
Healthcare
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OCTV
Octave Intelligence plc
Below Treasuries
Technology Risk 48 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OCUL
OCULAR THERAPEUTIX, INC
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +55.6%/yr vs model +4.5% · above model
ODC
Oil-Dri Corp of America
Below Treasuries
Consumer Cyclical Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ODD
Oddity Tech Ltd
Below Treasuries
Consumer Defensive Risk 57 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ODTX
Odyssey Therapeutics, Inc.
Below Treasuries
Healthcare Risk 58 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ODV
Osisko Development Corp.
Below Treasuries
Basic Materials Risk 52 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ODVWZ
Osisko Development Corp.
Below Treasuries
Basic Materials Risk 51 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ODYS
Odysight.ai Inc.
Below Treasuries
Technology Risk 27 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OFAL
OFA Group
Below Treasuries
Industrials Risk 76 · High
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +54.3%/yr vs model +2.0% · above model
OFRM
Once Upon a Farm, PBC
Below Treasuries
Consumer Defensive Risk 51 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OGC
OceanaGold Corp
Below Treasuries
Basic Materials
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OGEN
ORAGENICS INC
Below Treasuries
Healthcare Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +48.4%/yr vs model +15.0% · above model
OGI
ORGANIGRAM GLOBAL INC.
Below Treasuries
Healthcare Risk 32 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OIA
Invesco Municipal Income Opportunities Trust
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
OIM
OneIM Acquisition Corp.
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —